Coronavirus detection (SARS-CoV-2)

Scheme information

Service

EQAS

Scheme

SARS-CoV-2, detection

Service provider

Labquality

Accreditation

Not accredited

Status

Pilot round in May 2020, in production September 2020

Target

Laboratories and POCT

Coverage

Analytical phase

Rounds

4

Distributions

Only via distributors

Coordinator

Marsa Järvenpää

Expert

Products

5677 / SARS-CoV-2, antibody detection

Samples: 2 - 3 Anti-SARS-CoV-2 IgA/IgG/IgM pos/neg samples will be included (approx. 0,5 mL/sample). Samples will be one-donor/pooled samples of sera or plasma.

Type: Phycical sample

Examinations: SARS-CoV-2 IgA, IgG and IgM antibodies

Additional information:

5676 / SARS-CoV-2, nucleic acid detection

Samples: 2 pos/neg samples will be included either as liquid samples or as swab samples

Type: Phycical sample

Examinations: SARS-CoV-2 NAT

Additional information: The product used is a whole-genome workflow support tool that includes 100% of the genetic sequences of the virus and emulates real patient samples while being consistent, noninfectious, and stable. As such, it contains all possible NAT viral targets – ensuring compatibility across all nucleic acid tests.

Search other products Show similar products

Pin It on Pinterest

Share This